Last Updated on: 7th September 2019, 03:53 am
Based upon research publications and experience, Beike protocols also utilize umbilical cord mesenchymal stem cells (UCMSC) for appropriate conditions autoimmune and inflammatory diseases. These injections contain a higher percentage of mesenchymal stem cells than the umbilical cord blood stem cell injections and closely resemble the makeup of stem cells present in patient’s’ own bone marrow.
These cells not only secrete important cytokines and growth factors, such as brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factors (GDNF), transforming growth factor beta 1 (TGFβ1), Ciliary neurotrophic factor (CNTF), neurotrophin 3 (NT-3), which may play a role in neuroprotection; but also are able to differentiate into desired cell types. Last but not the least, UCMSC can regulate the immune system reducing inflammation, scarring, and cell death to keep organs and human body young and healthy and to improve the condition of degenerative diseases.
